首页> 外文期刊>Gastroenterology research and practice >Clinicopathological and Prognostic Characteristics of Hepatoid Adenocarcinoma of the Stomach
【24h】

Clinicopathological and Prognostic Characteristics of Hepatoid Adenocarcinoma of the Stomach

机译:胃肝样腺癌的临床病理和预后特征

获取原文
           

摘要

The present study was undertaken to clarify the association of the clinicopathological features of hepatoid adenocarcinoma (HAC) in the stomach, a special kind of carcinoma that histologically resembled hepatocellular carcinoma (HCC) and is characterized by large amounts ofα-fetoprotein (AFP) in serum, with the clinical prognosis. We collected the data of the clinicopathological features and the follow-up information from a total of 31 HACs from January 2005 to December 2012 in our hospital. High lymphatic (54.8%) and distant (25.8%) metastasis rates before surgery, large proportion of advanced HACs (71.0%) at admission, short median overall survival time (6 months), and low three-year survival rate (22.6%) suggested that HAC in the stomach was an aggressive disease, resulting in a poor prognosis. And pTNM stages, immunohistochemical staining of AFP, CEA, CK7, and CK20 had statistically relation with the survival as the independent risk factors,P<0.05. Therefore, early and clear differentiation of HAC from cancerous or noncancerous conditions with AFP elevation and assessment of high risk patients by histopathology may improve the clinical prognosis.
机译:进行本研究以阐明肝样腺癌(HAC)在胃中的临床病理特征的相关性,这是一种在组织学上类似于肝细胞癌(HCC)并以血清中大量α-甲胎蛋白(AFP)为特征的特殊癌,具有临床预后。从2005年1月至2012年12月,我们在医院收集了总共31个HAC的临床病理特征数据和随访信息。术前淋巴转移率高(54.8%)和远处转移率(25.8%),入院时晚期HAC比例高(71.0%),中位总生存时间短(6个月),三年生存率低(22.6%)提示胃中的HAC是一种侵袭性疾病,导致预后不良。 pTNM分期,AFP,CEA,CK7和CK20的免疫组织化学染色与生存率具有独立的统计学意义,P <0.05。因此,通过AFP升高将HAC从癌性或非癌性疾病中早期明确区分,并通过组织病理学评估高危患者可以改善临床预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号